Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis

Hiroyasu Fukui, Craig W. Reynolds, Barbara Lenz, Mark Schneider, James E. Talmadge

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis'. Together they form a unique fingerprint.

Medicine & Life Sciences